{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:27:44Z","timestamp":1780367264854,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ministry of Health, Welfare and Sport"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2020.03.002","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T09:28:48Z","timestamp":1584610128000},"page":"3321-3329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["HPV infections among young MSM visiting sexual health centers in the Netherlands: Opportunities for targeted HPV vaccination"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-7373","authenticated-orcid":false,"given":"Petra J.","family":"Woestenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit H.B.","family":"van Benthem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Bogaards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey J.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona R.M.","family":"van der Klis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hella","family":"Pasmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan","family":"Leussink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne A.B.","family":"van der Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J.P.A.","family":"Hoebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.03.002_b0005","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jadohealth.2010.01.016","article-title":"Beyond cervical cancer: burden of other HPV-related cancers among men and women","volume":"46","author":"Chaturvedi","year":"2010","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2020.03.002_b0010","unstructured":"European Medicines Agency. Cervarix: EPAR - Product Information. Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/cervarix [accessed 17-10-2019]."},{"key":"10.1016\/j.vaccine.2020.03.002_b0015","unstructured":"European Medicines Agency. Gardasil: EPAR - Product Information. Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/gardasil [accessed 17-10-2019]."},{"key":"10.1016\/j.vaccine.2020.03.002_b0020","unstructured":"European Medicines Agency. Gardasil 9: EPAR - Product Information. Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/gardasil-9 [accessed 17-10-2019]."},{"key":"10.1016\/j.vaccine.2020.03.002_b0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.002_b0030","unstructured":"World Health Organization. Global market study: HPV vaccines. Available at: https:\/\/apps.who.int\/iris\/handle\/10665\/311275 [accessed 16-12-2019]."},{"key":"10.1016\/j.vaccine.2020.03.002_b0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.03.002_b0040","unstructured":"WHO SAGE. Update on HPV vaccine introduction and programmatic perspectives. Available at: https:\/\/www.who.int\/immunization\/sage\/meetings\/2018\/october\/presentations_background_docs\/en\/index1.html [accessed 17-01-2020]."},{"key":"10.1016\/j.vaccine.2020.03.002_b0045","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/14760584.2018.1547196","article-title":"Ten years of HPV vaccination in the Netherlands: current evidence and future challenges in HPV-related disease prevention","volume":"17","author":"Qendri","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.03.002_b0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(16)30116-5","article-title":"Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study","volume":"17","author":"Chow","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.002_b0055","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1002\/ijc.31989","article-title":"Assessment of herd effects among women and heterosexual men after girls-only HPV16\/18 vaccination in the Netherlands: a repeated cross-sectional study","volume":"144","author":"Woestenberg","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2020.03.002_b0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/sextrans-2014-051813","article-title":"Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme","volume":"91","author":"Chow","year":"2015","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2020.03.002_b0065","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1470-2045(12)70080-3","article-title":"Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis","volume":"13","author":"Machalek","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2020.03.002_b0070","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/aje\/kwg067","article-title":"Cancer in a population-based cohort of men and women in registered homosexual partnerships","volume":"157","author":"Frisch","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2020.03.002_b0075","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cncr.20365","article-title":"Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer","volume":"101","author":"Daling","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2020.03.002_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002756","article-title":"Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: a multi-model approach","volume":"16","author":"Bogaards","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2020.03.002_b0085","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1016\/j.vaccine.2017.07.078","article-title":"Targeted human papillomavirus vaccination for young men who have sex with men in Australia yields significant population benefits and is cost-effective","volume":"35","author":"Zhang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.002_b0090","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.03.002_b0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.03.002_b0100","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/sextrans-2012-050900","article-title":"Hepatitis B vaccination of men who have sex with men in the Netherlands: should we vaccinate more men, younger men or high-risk men?","volume":"89","author":"Xiridou","year":"2013","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2020.03.002_b0105","doi-asserted-by":"crossref","DOI":"10.1136\/sextrans-2018-053923","article-title":"HPV vaccination of gay, bisexual and other men who have sex with men in sexual health and HIV clinics in England: vaccination uptake and attendances during the pilot phase","author":"Checchi","year":"2019","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2020.03.002_b0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/OLQ.0b013e318235b3b0","article-title":"Type-specific human papillomavirus infections among young heterosexual male and female STI clinic attendees","volume":"39","author":"Vriend","year":"2012","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2020.03.002_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060696","article-title":"Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection","volume":"8","author":"Vriend","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.002_b0120","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1016\/j.vaccine.2012.08.068","article-title":"Seroprevalence of seven high-risk HPV types in The Netherlands","volume":"30","author":"Scherpenisse","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.002_b0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ijc.26362","article-title":"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201325 years with and without serological evidence of previous exposure to HPV-16\/18","volume":"131","author":"Szarewski","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2020.03.002_b0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/bjc.2011.185","article-title":"End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24\u201345 years of age","volume":"105","author":"Castellsague","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2020.03.002_b0135","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/ciy274","article-title":"A Randomized, placebo-controlled trial of the quadrivalent human papillomavirus vaccine in human immunodeficiency virus-infected adults aged 27 years or older: AIDS clinical trials group protocol A5298","volume":"67","author":"Wilkin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.002_b0140","series-title":"Sexually transmitted infections in the Netherlands in 2016","author":"Visser","year":"2017"},{"key":"10.1016\/j.vaccine.2020.03.002_b0145","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1086\/522864","article-title":"Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection","volume":"196","author":"Future Ii Study Group","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.002_b0150","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/cid\/cir1036","article-title":"Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study","volume":"54","author":"Swedish","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.002_b0155","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/sextrans-2015-052032","article-title":"Comparison of age-specific patterns of sexual behaviour and anal HPV prevalence in homosexual men with patterns in women","volume":"92","author":"Poynten","year":"2016","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2020.03.002_b0160","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1158\/1055-9965.EPI-14-0199","article-title":"HPV seroconversion following anal and penile HPV infection in HIV-negative and HIV-infected MSM","volume":"23","author":"Mooij","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2020.03.002_b0165","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/infdis\/jiy276","article-title":"Detection of incident anal high-risk human papillomavirus DNA in men who have sex with men: incidence or reactivation?","volume":"218","author":"Twisk","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.002_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004113","article-title":"HPV clearance and the neglected role of stochasticity","volume":"11","author":"Ryser","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2020.03.002_b0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jinf.2014.06.003","article-title":"No evidence for a protective effect of naturally induced HPV antibodies on subsequent anogenital HPV infection in HIV-negative and HIV-infected MSM","volume":"69","author":"Mooij","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2020.03.002_b0180","doi-asserted-by":"crossref","first-page":"13573","DOI":"10.1073\/pnas.1714712114","article-title":"Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity","volume":"114","author":"Ranjeva","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2020.03.002_b0185","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1158\/1055-9965.EPI-10-1187","article-title":"Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women","volume":"20","author":"Gheit","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2020.03.002_b0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/infdis\/jix582","article-title":"Bivalent vaccine effectiveness against type-specific HPV positivity: evidence for cross-protection against oncogenic types among Dutch STI clinic visitors","volume":"217","author":"Woestenberg","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.002_b0195","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/bjc.2015.90","article-title":"Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies","volume":"112","author":"King","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2020.03.002_b0200","article-title":"Baseline HPV prevalence in rectal swabs from men attending a sexual health clinic in Scotland: assessing the potential impact of a selective HPV vaccination programme for men who have sex with men","author":"Cameron","year":"2019","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2020.03.002_b0205","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pvr.2017.02.003","article-title":"Vaccine-preventable anal human papillomavirus in Australian gay and bisexual men","volume":"3","author":"Poynten","year":"2017","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.vaccine.2020.03.002_b0210","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/infdis\/jiw232","article-title":"Monitoring for human papillomavirus vaccine impact among gay, bisexual, and other men who have sex with men-United States, 2012\u20132014","volume":"214","author":"Meites","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.002_b0215","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/cid\/ciw845","article-title":"Impact and cost-effectiveness of selective human papillomavirus vaccination of men who have sex with men","volume":"64","author":"Lin","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:01Z","timestamp":1759401721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20303303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":43,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X20303303"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HPV infections among young MSM visiting sexual health centers in the Netherlands: Opportunities for targeted HPV vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}